Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects.

[1]  J. Ritter,et al.  Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man , 1985, Nature.

[2]  P. D. de Groot,et al.  The role of thrombin in the regulation of the endothelial prostaglandin production. , 1985, Biochimica et biophysica acta.

[3]  R. de Caterina,et al.  Equal Antiplatelet Effects of Aspirin 50 or 324 mg/Day in Patients After Acute Myocardial Infarction , 1985, Thrombosis and Haemostasis.

[4]  G. Deichsel,et al.  DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASE A Prospective Double-Blind Arteriographically Controlled Trial , 1985, The Lancet.

[5]  B. Weksler,et al.  Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. , 1985, Circulation.

[6]  G. FitzGerald,et al.  Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. , 1984, The New England journal of medicine.

[7]  O. Ylikorkala,et al.  One milligramme of acetylsalicylic acid daily inhibits platelet thromboxane A2 production. , 1984, Thrombosis research.

[8]  V. Fuster,et al.  Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. , 1984, The New England journal of medicine.

[9]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[10]  B. Weksler,et al.  Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. , 1983, The New England journal of medicine.

[11]  M. Greaves,et al.  Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. , 1982, Thrombosis research.

[12]  C. Patrono,et al.  Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.

[13]  S. Heptinstall,et al.  DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS , 1981, The Lancet.

[14]  C. Stoddard,et al.  Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. , 1981, The New England journal of medicine.

[15]  P. Majerus,et al.  Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. , 1979, The New England journal of medicine.

[16]  P. Touboul,et al.  "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. , 1983, Stroke.